Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy

Akiyama MJ, Lipsey D, Heo M, et al. Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy. Clin Infect Dis. 2020;70(12):2695-2702.

Publication Type:

Journal Article

Authors:

Akiyama, MJ; Lipsey, D; Heo, M; et, al

Source:

Clin Infect Dis, Volume 70, Issue 12, p.2695-2702 (2020)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

Export Citation:

RIS Format

Top